MGP Ingredients Earnings Call: Premium Wins, Tough 2026

Mgp Ingredients ((MGPI)) has held its Q4 earnings call. Read on for the main highlights of the call.

MGP Ingredients’ latest earnings call painted a cautiously negative picture, blending bright spots in branded premium whiskey and recovering ingredients with steep declines in core distilling, a massive impairment charge, and weaker guidance for 2026. Management emphasized cost discipline and strategic progress, but acknowledged that the coming year will be difficult as industry headwinds and higher leverage weigh on results.

Penelope and Premium Plus Brands Buck Industry Slowdown

Penelope Bourbon was the clear star, with Nielsen data showing 80% dollar sales growth over the past year, making it the second‑fastest growing brand among top Premium Plus American whiskeys. The broader Premium Plus portfolio outpaced the category by 900 basis points, with Q4 Premium Plus sales up 10% and Penelope doubling distribution points while increasing velocity 12%.

Cash Generation Strengthens as Capital Spending Tightens

Operating cash flow for fiscal 2025 rose 19% to $122 million, giving MGP more flexibility amid weaker earnings. Management sharply reduced barrel put‑away to $19 million in 2025 and cut CapEx more than 50% to $32 million, with 2026 CapEx guided to about $20 million and underlying free cash flow expected at $20–25 million excluding the Penelope earn‑out.

Strategic Review Drives Leadership Changes and Cost Controls

Following an enterprise‑wide strategic review, MGP refreshed its senior ranks with a new CMO, SVP of Operations, and SVP of Strategy & Insights, and pushed productivity into daily routines. Adjusted SG&A, excluding reinstated incentives, fell about 5% in Q4 and 4% for the year, while A&P was realigned and reduced 11% in Q4 and 23% for 2025 to better support priority brands.

Ingredient Solutions Rebounds and Targets Double‑Digit Growth

The Ingredient Solutions segment showed improving momentum as extrusion protein sales hit a new Q4 high and commercial demand stayed strong. With a key equipment outage resolved in November, management now targets 2026 Ingredient Solutions sales of $140–150 million and mid‑to‑high‑teens gross margins, implying strong double‑digit growth as reliability improves.

Rationalizing the Portfolio to Fund Premium Plus Marketing

MGP is pruning roughly 20% of tail brands through a cross‑functional portfolio process to cut complexity and redeploy resources. Branded Spirits A&P was about 12.5% of segment sales in 2025 and is expected to tick up to roughly 13.5% in 2026, backed by a planned more‑than‑200% increase in digital media and a streamlined agency model focused on Premium Plus labels.

Distilling Solutions Repositions Amid Brown Goods Weakness

Even as brown spirits remain under pressure, the company is broadening premium white goods offerings, pursuing private‑label aged whiskey, and expanding warehouse services to deepen customer ties. These efforts helped brown goods results land modestly ahead of the company’s initial outlook, though they do not offset the broader downturn in the segment.

Core FY2025 Results Show Profitability Despite Headwinds

For fiscal 2025, MGP reported consolidated sales of $536 million, adjusted EBITDA of $116 million, and adjusted basic EPS of $2.85, confirming that the business remains solidly profitable on an adjusted basis. These results were achieved despite mounting pressures in Distilling Solutions and higher SG&A tied to reinstated performance incentives.

Quarterly Sales and Margins Slide Sharply in Q4

The fourth quarter underscored the deterioration, with consolidated sales down 23% year over year to $138 million and gross profit off 35% to $48 million. Q4 gross margin contracted 630 basis points to 34.9%, while adjusted EBITDA plunged 51% to $26 million and adjusted basic EPS fell 60% to $0.63, highlighting the near‑term earnings squeeze.

Distilling Solutions Suffers a Severe Sales and Profit Collapse

Distilling Solutions was the main drag, with Q4 sales tumbling 47%, including a 53% drop in brown goods, and full‑year segment sales down 45% alongside a 52% decline in gross profit. Management now expects another leg down in 2026, guiding Distilling Solutions sales to fall about 35% and gross profit roughly 40% versus 2025 levels.

Non‑Cash Impairment Drives Large Reported Net Loss

The company posted a Q4 net loss of $135 million, largely due to a $153 million non‑cash impairment charge tied to goodwill and certain indefinite‑lived intangibles in the Branded Spirits segment. This write‑down translated into a reported basic loss of $6.22 per share, masking the still positive adjusted earnings profile.

Leverage to Peak as Penelope Earn‑Out and Refinancing Loom

MGP’s balance sheet will be tested in 2026 as it makes a $111 million earn‑out payment for Penelope in the second quarter and refinances $201 million of convertible notes in the fourth quarter. The Penelope payment alone will cut 2026 operating cash flow by nearly $50 million, and management expects net debt leverage to peak around 3.75 times EBITDA.

Waste Disposal Costs Weigh on Ingredient Solutions Margins

Ingredient Solutions also faced operational setbacks in 2025, including the extrusion outage and elevated waste stream disposal costs that dragged through year‑end. Management warned that some of these disposal expenses will linger in the near to medium term and that fully eliminating waste costs will be a multiquarter effort, delaying margin normalization.

Margins Under Pressure as Sales Fall and SG&A Mix Shifts

On a full‑year basis, consolidated gross margin fell 350 basis points to 37.2% as mix and volume pressures intensified, particularly in Distilling Solutions. Adjusted SG&A jumped 18% in Q4 due to restored incentives, and total company SG&A is expected to reach roughly 18% of sales in 2026, rising mainly because the sales base is shrinking rather than costs surging.

Industry Oversupply and Production Cuts Darken the Backdrop

External data underscore the cyclical downturn, with domestic whiskey production down 26% over the trailing year and nearly 30% over the last six months. Management believes the broader spirits industry will remain below historical growth rates and that 2026 is likely to be another down year, prolonging the recovery timeline for brown spirits.

Guidance Signals Another Tough Year Before Recovery

For 2026, management guided net sales of $480–500 million, adjusted EBITDA of $90–98 million, and adjusted EPS of $1.50–1.80, all below 2025 levels, with Q1 expected to be the weakest quarter at about 15% of full‑year EBITDA. Branded Spirits is seen down mid‑single digits with slightly better margins, Distilling Solutions down sharply again, and Ingredient Solutions driving growth with sales of $140–150 million and improving margins as the year progresses.

The call left investors with a nuanced outlook in which strong premium brands, solid cash generation, and a growing ingredients franchise are battling against deep cyclical pain in distilling, margin pressure, and higher leverage. Management is leaning on cost discipline, portfolio focus, and selective investment to navigate a challenging 2026, arguing that today’s lower baseline sets the stage for a healthier, more focused MGP when the spirits cycle eventually turns.